Pre-existing Fc profiles shape the evolution of neutralizing antibody breadth following influenza vaccination

被引:3
|
作者
Boudreau, Carolyn M. [1 ,2 ]
Burke IV, John S. [2 ]
Roederer, Alexander L. [1 ,2 ]
Gorman, Matthew J. [2 ]
Mundle, Sophia [3 ]
Lingwood, Daniel [2 ]
Delagrave, Simon [4 ]
Sridhar, Saranya [3 ]
Ross, Ted M. [5 ]
Kleanthous, Harry [6 ]
Alter, Galit [2 ]
机构
[1] Harvard Univ, Program Virol, Div Med Sci, Boston, MA 02115 USA
[2] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA
[3] Sanofi Pasteur Inc, Discovery North Amer, Cambridge, MA 02139 USA
[4] Ring Therapeut, Cambridge, MA 02139 USA
[5] Univ Georgia, Athens, GA 30602 USA
[6] Bill & Melinda Gates Fdn, Seattle, WA 98109 USA
关键词
IMMUNE-COMPLEXES; GAMMA RECEPTOR; AFFINITY; MOUSE; DIVERSIFICATION; SUSCEPTIBILITY; AUTOIMMUNITY; INHIBITION; ACTIVATION; INFECTION;
D O I
10.1016/j.xcrm.2023.100975
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Under the ever-present threat of a pandemic influenza strain, the evolution of a broadly reactive, neutralizing, functional, humoral immune response may hold the key to protection against both circulating and emerging influenza strains. We apply a systems approach to profile hemagglutinin-and neuraminidase-specific humor -al signatures that track with the evolution of broad immunity in a cohort of vaccinated individuals and validate these findings in a second longitudinal cohort. Multivariate analysis reveals the presence of a unique pre-ex-isting Fcg-receptor-binding antibody profile in individuals that evolved broadly reactive hemagglutination inhibition activity (HAI), marked by the presence of elevated levels of pre-existing FCGR2B-binding antibodies. Moreover, vaccination with FCGR2B-binding antibody-opsonized influenza results in enhanced antibody titers and HAI activity in a murine model. Together, these data suggest that pre-existing FCGR2B binding antibodies are a key correlate of the evolution of broadly protective influenza-specific antibodies, providing insight for the design of next-generation influenza vaccines.
引用
收藏
页数:21
相关论文
共 50 条
  • [21] The Pre-Existing Human Antibody Repertoire to Computationally Optimized Influenza H1 Hemagglutinin Vaccines
    Nagashima, Kaito
    Dzimianski, John, V
    Han, Julianna
    Abbadi, Nada
    Gingerich, Aaron D.
    Royer, Fredejah
    O'Rourke, Sara
    Sautto, Giuseppe A.
    Ross, Ted M.
    Ward, Andrew B.
    DuBois, Rebecca M.
    Mousa, Jarrod J.
    JOURNAL OF IMMUNOLOGY, 2022, 209 (01): : 5 - 15
  • [22] Impact of age and pre-existing immunity on the induction of human antibody responses against influenza B viruses
    Carlock, Michael A.
    Ingram, John G.
    Clutter, Emily F.
    Cecil, Noah C.
    Ramgopal, Moti
    Zimmerman, Richard K.
    Warren, William
    Kleanthous, Harry
    Ross, Ted M.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2019, 15 (09) : 2030 - 2043
  • [23] Identification of a broad-inhibition influenza neuraminidase antibody from pre-existing memory B cells
    Wang, Xin
    Kong, Huihui
    Chu, Bingxin
    Yang, Qian
    Lin, Chaohui
    Liu, Rui
    Chen, Changxu
    Gao, Yang
    Wang, Guojun
    Wang, Dayan
    Qin, Chen
    Ye, Xiaohua
    Yu, Lifei
    Xu, Xiangfei
    Jin, Jie
    Sun, Ren
    Chen, Hualan
    Wu, Xudong
    Zhang, Zeli
    CELL HOST & MICROBE, 2025, 33 (01)
  • [24] Characterization of Pre-Existing Neutralizing Antibody to Human Adenovirus Types 5 and 49 and Simian Type 23 in Chinese Population
    Zou, Peng
    Wang, Qi
    Zhang, Panli
    Luo, Shengxue
    Wang, Cong
    Zhang, Enhui
    Zhang, Ling
    Li, Chengyao
    Li, Tingting
    VIRAL IMMUNOLOGY, 2023, 36 (09) : 617 - 625
  • [25] IgM responses following SARS-CoV-2 vaccination: insights into protective and pre-existing immunity
    Fraussen, Judith
    EBIOMEDICINE, 2022, 77
  • [26] Pre-existing SARS-CoV-2 immunity influences potency, breadth, and durability of the humoral to SARS-CoV-2 vaccination
    Mantus, Grace
    Nyhoff, Lindsay E.
    Edara, Venkata-Viswanadh
    Zarnitsyna, Veronika, I
    Ciric, Caroline R.
    Flowers, Maria W.
    Norwood, Carson
    Ellis, Madison
    Hussaini, Laila
    Manning, Kelly E.
    Stephens, Kathy
    Anderson, Evan J.
    Ahmed, Rafi
    Suthar, Mehul S.
    Wrammert, Jens
    CELL REPORTS MEDICINE, 2022, 3 (04)
  • [27] Pre-existing yellow fever immunity impairs and modulates the antibody response to tick-borne encephalitis vaccination
    Bradt, Victoria
    Malafa, Stefan
    von Braun, Amrei
    Jarmer, Johanna
    Tsouchnikas, Georgios
    Medits, Iris
    Wanke, Kerstin
    Karrer, Urs
    Stiasny, Karin
    Heinz, Franz X.
    NPJ VACCINES, 2019, 4 (1)
  • [28] Pre-existing yellow fever immunity impairs and modulates the antibody response to tick-borne encephalitis vaccination
    Victoria Bradt
    Stefan Malafa
    Amrei von Braun
    Johanna Jarmer
    Georgios Tsouchnikas
    Iris Medits
    Kerstin Wanke
    Urs Karrer
    Karin Stiasny
    Franz X. Heinz
    npj Vaccines, 4
  • [29] Intermediate Levels of Pre-Existing Protective Antibody Allow Priming of Protective T Cell Immunity against Influenza
    Ng, Terry
    Flores-Malavet, Valeria
    Mansoor, Mishfak A. M.
    Arvelo, Andrea C.
    Dhume, Kunal
    Prokop, Emily
    McKinstry, K. Kai
    Strutt, Tara M.
    JOURNAL OF IMMUNOLOGY, 2023, 210 (05): : 628 - 639
  • [30] EFFECTIVENESS OF CHOLERA TOXIN-B SUBUNIT AS AN ADJUVANT FOR NASAL INFLUENZA VACCINATION DESPITE PRE-EXISTING IMMUNITY TO CTB
    TAMURA, S
    FUNATO, H
    NAGAMINE, T
    AIZAWA, C
    KURATA, T
    VACCINE, 1989, 7 (06) : 503 - 505